Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 512

1.

Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.

Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr.

J Natl Cancer Inst. 2012 Jul 18;104(14):1094-101. doi: 10.1093/jnci/djs264. Epub 2012 Jul 5.

2.

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.

Kurian AW, Fish K, Shema SJ, Clarke CA.

Breast Cancer Res. 2010;12(6):R99. doi: 10.1186/bcr2780. Epub 2010 Nov 19.

3.

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.

Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, Burkman RT, Strom BL, McDonald JA, Folger SG, Simon MS, Sullivan-Halley J, Press MF, Bernstein L.

BMC Cancer. 2013 May 4;13:225. doi: 10.1186/1471-2407-13-225.

4.

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.

Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW.

Cancer. 2010 Jun 1;116(11):2549-59. doi: 10.1002/cncr.25016.

5.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW.

Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3. Epub 2008 Mar 7.

PMID:
18324472
6.

Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.

Parise C, Caggiano V.

Cancer Epidemiol. 2014 Oct;38(5):556-62. doi: 10.1016/j.canep.2014.08.001. Epub 2014 Sep 22.

PMID:
25172158
7.

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA.

J Natl Cancer Inst. 2014 Apr 28;106(5). pii: dju055. doi: 10.1093/jnci/dju055.

8.

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L.

J Natl Cancer Inst. 2015 Mar 30;107(6):djv048. doi: 10.1093/jnci/djv048. Print 2015 Jun. Erratum in: J Natl Cancer Inst. 2015 May;107(5). pii: djv121. doi: 10.1093/jnci/djv121. J Natl Cancer Inst. 2015 Jul;107(7). pii: djv177. doi: 10.1093/jnci/djv177.

9.
10.
11.

Occurrence of breast cancer subtypes in adolescent and young adult women.

Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA.

Breast Cancer Res. 2012 Mar 27;14(2):R55.

12.
13.
14.

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

Tumori. 2010 Jan-Feb;96(1):103-10.

15.

Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.

Dickens C, Duarte R, Zietsman A, Cubasch H, Kellett P, Schüz J, Kielkowski D, McCormack V.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2311-21. doi: 10.1158/1055-9965.EPI-14-0603. Epub 2014 Aug 20.

16.

Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR.

J Clin Oncol. 2015 Dec 20;33(36):4267-76. doi: 10.1200/JCO.2015.63.7801. Epub 2015 Nov 23.

PMID:
26598753
17.

A population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data.

Runnak MA, Hazha MA, Hemin HA, Wasan AA, Rekawt RM, Michael HD.

BMC Womens Health. 2012 Jun 22;12:16. doi: 10.1186/1472-6874-12-16.

18.

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI.

J Natl Cancer Inst. 2011 Mar 16;103(6):470-7. doi: 10.1093/jnci/djr030. Epub 2011 Feb 23.

19.

Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.

Puig-Vives M, Sánchez MJ, Sánchez-Cantalejo J, Torrella-Ramos A, Martos C, Ardanaz E, Chirlaque MD, Perucha J, Díaz JM, Mateos A, Machón M, Marcos-Gragera R.

Gynecol Oncol. 2013 Sep;130(3):609-14. doi: 10.1016/j.ygyno.2013.05.039. Epub 2013 Jun 6.

PMID:
23747837
Items per page

Supplemental Content

Write to the Help Desk